Breaking News Instant updates and real-time market news.

ABT

Abbott

$86.34

3.23 (3.89%)

09:56
07/17/19
07/17
09:56
07/17/19
09:56

Abbott says 'running as fast as we can in Europe'

Says: Has paid down a 'significant amount of debt'...Investing in manufacturing... Plans to maintain/grow a strong, healthy dividend... Does not feel the need for M&A right now or in the near future.

  • 17

    Jul

ABT Abbott
$86.34

3.23 (3.89%)

04/03/19
JPMS
04/03/19
NO CHANGE
Target $175
JPMS
Overweight
JPMorgan remains 'very bullish' on DexCom despite Libre 2.0 uncertainty
The latest DexCom (DXCM) controversy is "whirling speculation" around Abbott's (ABT) Libre 2.0 launch, JPMorgan analyst Robbie Marcus tells investors in a research note. The analyst keeps an Overweight rating on DexCom shares with a $175 price target but expects uncertainty over Libre 2.0 to remain an overhang until it receives U.S. approval. However, he remains "very bullish" on the shares and sees "significant upside" to 2019 estimates. DexComis the best positioned in diabetes longer-term, Marcus contends.
04/15/19
RBCM
04/15/19
NO CHANGE
Target $82
RBCM
Sector Perform
Abbott price target raised to $82 from $77 at RBC Capital
RBC Capital analyst Brandon Henry raised his price target on Abbott to $82 ahead of its Q1 results, saying the "pattern of revenue growth" seen last year should continue this quarter as Core Laboratory, Electrophysiology, Structural Heart, and Diabetes Care product categories "lead the way." The analyst also expects Abbott's organic revenue growth in the Medical Devices segment to come at the high end of guidance, adding that while his new price target implies a multiple of 22.5-times vs. peer group's 21-times, he believes that the company's growth profile justifies the valuation premium. Henry recommends that investors buy the stock on "any weakness".
04/18/19
LSCM
04/18/19
NO CHANGE
Target $100
LSCM
Buy
Investors should buy into Tandem Diabetes 'fire sale,' says Lake Street
Lake Street analyst Brooks O'Neil attributes the recent selloff in shares of Tandem Diabetes (TNDM) to investor fears related to the potential implications of "Medicare For All." Yesterday, the decline also appeared to "draw fuel from the strong growth" Abbott (ABT) reported for its Libre glucose monitor for diabetics, O'Neil tells investors in a research note titled "Fire Sale. Should You Buy? Yes. There Is No Fire. Affirm BUY, $100 PT." The analyst doubts the healthcare system will be changed significantly and on Libre, he says, "We're sorry, but we believe investors are either badly confused or just plain wrong." Abbott offers a low-cost version of the monitoring system but does not compete in any way with Tandem in its pump market, says the analyst. Rather, O'Neil thinks there are "potentially significant positives" for Tandem Diabetes related to the "enormous success" of Abbott's Libre franchise. The analyst sees an "extraordinarily positive" outlook for Tandem Diabetes and recommends buying the shares on the recent pullback. He affirms a Buy rating on the shares with a $100 price target.
04/29/19
PIPR
04/29/19
NO CHANGE
Target $165
PIPR
Overweight
Piper reiterates Overweight on DexCom after 'robust' teen survey results
There were 8,042 responses to Piper Jaffray's teen survey in February and March, of which 1,707 have diabetes or a member of their household does, analyst JP McKim tells investors in a research note. The survey implies underlying continuous glucose monitoring market growth of close to 58%, says the analyst. Abbott (ABT) reported 70% Libre growth in Q1 and DexCom (DXCM) reports May 1, McKim points out. He expects "continued strong growth" from DexCom following the "robust" survey results and reiterates an Overweight rating on the shares with a $165 price target.

TODAY'S FREE FLY STORIES

LMT

Lockheed Martin

$373.76

0.6 (0.16%)

06:37
10/23/19
10/23
06:37
10/23/19
06:37
Hot Stocks
Lockheed Martin awarded Air Force ICBM contract »

The U.S. Air Force has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSI

Stage Stores

$2.24

0.09 (4.19%)

, AMZN

Amazon.com

$1,766.07

-18.66 (-1.05%)

06:37
10/23/19
10/23
06:37
10/23/19
06:37
Hot Stocks
Stage Stores announces in-store package pick-up with Amazon Hub Counter »

Stage Stores (SSI)…

SSI

Stage Stores

$2.24

0.09 (4.19%)

AMZN

Amazon.com

$1,766.07

-18.66 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

MKTX

MarketAxess

$340.76

-12.61 (-3.57%)

06:36
10/23/19
10/23
06:36
10/23/19
06:36
Hot Stocks
MarketAxess raises 2019 CapEx view to $31M-$33M from $25M-$30M »

Backs 2019 expense view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CAT

Caterpillar

$133.69

1.47 (1.11%)

06:36
10/23/19
10/23
06:36
10/23/19
06:36
Hot Stocks
Caterpillar says decline in sales driven mainly by dealer inventory decrease »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

LTXB

LegacyTexas Financial

$44.04

0.22 (0.50%)

06:36
10/23/19
10/23
06:36
10/23/19
06:36
Earnings
LegacyTexas Financial reports Q3 EPS 90c, consensus 83c »

Reports Q3 tangible book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

ALXN

Alexion

$99.22

-1.38 (-1.37%)

06:35
10/23/19
10/23
06:35
10/23/19
06:35
Hot Stocks
Alexion CEO says 'delivered another record performance' in Q3 »

"With consistent and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

PB

Prosperity Bancshares

$71.60

0.33 (0.46%)

06:35
10/23/19
10/23
06:35
10/23/19
06:35
Hot Stocks
Prosperity Bancshares raises dividend by 12.2% to 46c per share »

Prosperity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MKTX

MarketAxess

$340.76

-12.61 (-3.57%)

06:35
10/23/19
10/23
06:35
10/23/19
06:35
Earnings
MarketAxess reports Q3 EPS $1.42, consensus $1.39 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BSX

Boston Scientific

$38.21

-0.45 (-1.16%)

06:34
10/23/19
10/23
06:34
10/23/19
06:34
Earnings
Boston Scientific narrows FY19 adjusted EPS view to $1.55-$1.58 from $1.54-$1.58 »

Consensus is $1.56.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

CAT

Caterpillar

$133.69

1.47 (1.11%)

06:34
10/23/19
10/23
06:34
10/23/19
06:34
Earnings
Caterpillar cuts FY19 EPS view to $10.90-$11.40 from 'low end' of $12.06-$13.06 »

Consensus $11.70. Both…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

PB

Prosperity Bancshares

$71.60

0.33 (0.46%)

06:34
10/23/19
10/23
06:34
10/23/19
06:34
Earnings
Prosperity Bancshares reports Q3 EPS $1.19, consensus $1.18 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HRI

Herc Holdings

$47.02

-0.295 (-0.62%)

06:34
10/23/19
10/23
06:34
10/23/19
06:34
Hot Stocks
Breaking Hot Stocks news story on Herc Holdings »

Herc Holdings raises 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Dec

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

06:33
10/23/19
10/23
06:33
10/23/19
06:33
Recommendations
ServiceNow analyst commentary  »

Macquarie a buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Dec

  • 12

    Dec

BSX

Boston Scientific

$38.21

-0.45 (-1.16%)

06:33
10/23/19
10/23
06:33
10/23/19
06:33
Earnings
Boston Scientific sees Q4 adjusted EPS 42c-45c, consensus 44c »

Sees Q4 revenue growth,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

HRI

Herc Holdings

$47.02

-0.295 (-0.62%)

06:33
10/23/19
10/23
06:33
10/23/19
06:33
Earnings
Herc Holdings reports Q3 adjusted EPS $1.48, consensus $1.63 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Dec

ALXN

Alexion

$99.22

-1.38 (-1.37%)

06:32
10/23/19
10/23
06:32
10/23/19
06:32
Earnings
Alexion raises FY19 adj. EPS view to $10.25-$10.40 from $9.65-$9.85 »

FY19 consensus $9.94.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

CAT

Caterpillar

$133.69

1.47 (1.11%)

06:32
10/23/19
10/23
06:32
10/23/19
06:32
Earnings
Caterpillar reports Q3 EPS $2.66, consensus $2.88 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

BSX

Boston Scientific

$38.21

-0.45 (-1.16%)

06:32
10/23/19
10/23
06:32
10/23/19
06:32
Earnings
Boston Scientific reports Q3 adjusted EPS 39c, consensus 38c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

LLY

Eli Lilly

$110.00

2.06 (1.91%)

06:31
10/23/19
10/23
06:31
10/23/19
06:31
Earnings
Eli Lilly raises FY19 EPS view to $5.75-$5.85 from $5.67-$5.77, consensus $5.72 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

LIN

Linde plc

$191.42

-3.605 (-1.85%)

06:30
10/23/19
10/23
06:30
10/23/19
06:30
Hot Stocks
Linde plc acquires minority stake in ITM Power, agrees to form JV »

Linde announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ALXN

Alexion

$99.22

-1.38 (-1.37%)

06:30
10/23/19
10/23
06:30
10/23/19
06:30
Earnings
Alexion reports Q3 adjusted EPS $2.79, consensus $2.47 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

CADE

Cadence Bancorp

$17.95

0.24 (1.36%)

06:30
10/23/19
10/23
06:30
10/23/19
06:30
Earnings
Cadence Bancorp reports Q3 EPS 34c, consensus 49c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

PG

Procter & Gamble

06:29
10/23/19
10/23
06:29
10/23/19
06:29
Recommendations
Procter & Gamble analyst commentary  »

Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

06:29
10/23/19
10/23
06:29
10/23/19
06:29
Recommendations
ServiceNow analyst commentary  »

ServiceNow stock price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Dec

  • 12

    Dec

LLY

Eli Lilly

$110.00

2.06 (1.91%)

06:29
10/23/19
10/23
06:29
10/23/19
06:29
Earnings
Eli Lilly reports Q3 EPS $1.48, consensus $1.40 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.